Science Explorer Back to mapMap
Discussion
Researcher · Gedeon Richter (Hungary) · Hungary

Mónika Vastag

Mónika Vastag publishes mostly in Molecular Biology, Neurology and Cellular and Molecular Neuroscience, on topics such as Receptor Mechanisms and Signaling, Pharmacological Receptor Mechanisms and Effects and Barrier Structure and Function Studies.

OpenAlex
World rank
#2,564,567
of 7,710,434 ranked researchers
Rank in Hungary
#4,434
of 25,218
Works
55
Citations
1.5k
Citations per work
27.5
h-index
20
i10-index 29Top 33% in Molecular Biology
Mónika Vastag

What does Mónika Vastag research?

Mónika Vastag's work is mostly in Biochemistry, Genetics and Molecular Biology (32%), Neuroscience (20%), Medicine (9%).

Life Sciences: 31 works · 55.7% of their workBiochemistry, Genetics and Molecular Biology: 17 works · 31.6% of their workMolecular Biology: 17 works · 31.6% of their workNeuroscience: 11 works · 19.7% of their workNeurology: 6 works · 10.8% of their workCellular and Molecular Neuroscience: 5 works · 8.9% of their workPharmacology, Toxicology and Pharmaceutics: 2 works · 4.4% of their workPharmaceutical Science: 2 works · 4.4% of their workEverything else: 19 works · 35.4% of their workHealth Sciences: 5 works · 8.9% of their workMedicine: 5 works · 8.9% of their workOncology: 3 works · 5.1% of their workPharmacology: 2 works · 3.8% of their workTHEIR WORKMónika Vastag55works
Life Sciences56%Health Sciences9%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1731.6%
    2. Neuroscience1119.7%
    3. Pharmacology, Toxicology and Pharmaceutics24.4%
  2. Everything else1935.4%
    1. Medicine58.9%
  1. 1Molecular Biology32% of their works
  2. 2Neurology11% of their works
  3. 3Cellular and Molecular Neuroscience9% of their works
  4. 4Oncology5% of their works
  5. 5Pharmaceutical Science4% of their works
  6. 6Pharmacology4% of their works

Research topics

Which keywords describe Mónika Vastag's research?

The keywords of their largest research topics: Crystal Structure, Pharmacology, Neurodegenerative Diseases, G-Protein-Coupled Receptors, Signal Transduction, Chaperone, Sigma-1 Receptor and Blood-Brain Barrier.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Crystal Structure202 topics
  2. Pharmacology182 topics
  3. Neurodegenerative Diseases172 topics
  4. G-Protein-Coupled Receptors141 topic
  5. Signal Transduction141 topic
  6. Chaperone131 topic
  7. Sigma-1 Receptor131 topic
  8. Blood-Brain Barrier121 topic
  9. Neurovascular Unit121 topic
  10. Alzheimer's Disease102 topics
  11. Neurotransmission101 topic
  12. Synaptic Plasticity101 topic
  13. ATP-dependent Transporters81 topic
  14. Multidrug Resistance81 topic
  15. Neuronal Signaling61 topic
  16. Nicotinic Acetylcholine Receptors61 topic
  17. Chitosan51 topic
  18. Nanoparticles51 topic
  19. Acetylcholinesterase41 topic
  20. Cholinesterase Inhibitors41 topic

Where does Mónika Vastag work?

Mónika Vastag's main affiliation in the publication record is Gedeon Richter (Hungary), Hungary.

How many publications and citations does Mónika Vastag have?

OpenAlex counts 55 works and 1,514 citations for Mónika Vastag, an h-index of 20, ranking #2,564,567 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mónika Vastag. Posts are plain text and can be reported.